Qingbo Xu

3.7k citations
46 papers · 3.0k indexed · h-index 21
Topics
Atherosclerosis and Cardiovascular Diseases (13 papers)Heat shock proteins research (8 papers)Melanoma and MAPK Pathways (5 papers)

In The Last Decade

Qingbo Xu

43 papers receiving 2.9k citations

Peers

Qingbo Xu
Comparison fields: 5 of 118
  • Molecular Biology 1.7k
  • Immunology 1000
  • Cell Biology 394
  • Physiology 326
  • Rheumatology 317
Replace Suk‐Hwan Baek with:
Suk‐Hwan Baek South Korea
Hidetoshi Hayashi Japan
Chris J. Weston United Kingdom
Latifa Bakiri Austria
P. Rieber Germany
Jean‐Baptiste Demoulin Belgium
Michitaka Ozaki Japan
Murray C.H. Clarke United Kingdom
Arndt Schottelius Germany
Carole Peyssonnaux France
Qingbo Xu relative to Suk‐Hwan Baek South Korea Suk‐Hwan Baek's profile →
Citations per field
00.5×2.8×
Suk‐Hwan Baek · 1×
Citations per year

Countries citing papers authored by Qingbo Xu

Since Specialization
Citations

This map shows the geographic impact of Qingbo Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingbo Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingbo Xu more than expected).

Fields of papers citing papers by Qingbo Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingbo Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingbo Xu. The network helps show where Qingbo Xu may publish in the future.

Co-authorship network of co-authors of Qingbo Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingbo Xu. A scholar is included among the top collaborators of Qingbo Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingbo Xu. Qingbo Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 6
5 6
6 3
7 16
8 12
9 0
10 2
11 4
12 64
13
Combined proteomic and metabolomic analysis of vascular smooth muscle cells: role of PKCdelta
3
14 328
15 239
16 69
17 27
18 187
19 3
20 168

About Qingbo Xu

Qingbo Xu is a scholar working on Immunology, Physiology and Aging, having authored 46 papers that have together received 3.0k indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (13 papers), Heat shock proteins research (8 papers) and Melanoma and MAPK Pathways (5 papers). The work is most often cited by research in Immunology (1000 citations), Immunology and Allergy (187 citations) and Molecular Biology (1.7k citations). Qingbo Xu has collaborated with scholars based in Austria, China and United Kingdom. Frequent co-authors include Chaohong Li, Nikki J. Holbrook, Liu Y, Myriam Gorospe, Roman Kleindienst, Georg Wick, Georg Wick, Johann Willeit, Georg Schett and Kathryn Z. Guyton. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026